Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
NCT ID: NCT01349517
Last Updated: 2011-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
400 participants
INTERVENTIONAL
2011-05-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To compare the impact of different procedures on the the health-related quality of life of patients with esophageal cancer.
* To compare morbidities and oncological results(3,5- year survival) from different procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MIE Group
The patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)
MIE
The patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)
Three-incision esophagectomy group
The patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)
Three-incision thoracotomy
The patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)
Ivor-Lewis esophagectomy group
The patients in this group would underwent Ivor-Lewis esophagectomy
Ivor-Lewis esophagectomy
The patients in this group would underwent Ivor-Lewis esophagectomy
Sweet esophagectomy group
The patients in this group would underwent Sweet esophagectomy.
Sweet esophagectomy
The patients in this group would underwent Sweet esophagectomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIE
The patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)
Three-incision thoracotomy
The patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)
Ivor-Lewis esophagectomy
The patients in this group would underwent Ivor-Lewis esophagectomy
Sweet esophagectomy
The patients in this group would underwent Sweet esophagectomy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal blood test of basic metabolism panel
* Pulmonary function: FEV1 \> 1.2L, FEV1% \> 50%, DLCO \> 50%
* Heart function: NY grade I and grade II
Exclusion Criteria
* Combination with other cancers
* With a previous history of thoracic or ventral surgery
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Hospital of Jilin University
OTHER
Fujian Medical University Union Hospital
OTHER
Shanxi Province Cancer Hospital
OTHER
Wuxi People's Hospital
OTHER
Linyi People's Hospital
OTHER
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhong Shan Hospital, Fu Dan University, Shanghai, China,
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lijie Tan, MD
Role: STUDY_CHAIR
Zhongshan Hospital, Fudan University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhong Shan Hospital, Fu Dan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZSchest2011001
Identifier Type: -
Identifier Source: org_study_id